Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Zhang, Yue ^a   Li, Wenzhong ^a,b   Ou, Lailiang ^a   Wang, Weiwei ^a,b   Delyagina, Evgenya ^a   Lux, Cornelia ^a   Sorg, Heiko ^c   Riehemann, Kristina ^d   Steinhoff, Gustav ^a   Ma, Nan ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN; LUCIFERASE; MAGNETIC NANOPARTICLE; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENE; GENE EXPRESSION PROFILING; GENE LOCATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE GENE; MAGNETIC FIELD; MALE; NANOPHARMACEUTICS; NONHUMAN; RAT; SIGNAL TRANSDUCTION; TISSUE REGENERATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULOTROPIN GENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; ARTERIOLES; CAPILLARIES; FEASIBILITY STUDIES; HEART; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNETIC FIELDS; MAGNETS; MALE; MYOCARDIAL INFARCTION; NANOPARTICLES; RATS; REGENERATION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84864381300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039490     Document Type: Article

References (41)

1. [Anon] (2004) The World Health Report 2004 - Changing history. Journal of Advanced Nursing 48: 542-542.
2. Tamura K, Nakajima H, Rakue H, Sasame A, Naito Y, et al. (1999) Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 63: 357-361.
3. Yin R, Feng J, Yao Z, (2000) Dynamic changes of serum vascular endothelial growth factor levels in a rat myocardial infarction model. Chin Med Sci J 15: 154-156.
4. Yin R, Feng J, Chen D, Wu H, (2000) Serum levels of vascular endothelial growth factor in patients with angina pectoris and acute myocardial infarction. Chin Med Sci J 15: 205-209.
5. Laguens R, Cabeza Meckert P, Vera Janavel G, Del Valle H, Lascano E, et al. (2002) Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer. Gene Ther 9: 1676-1681.
6. Ferrarini M, Arsic N, Recchia FA, Zentilin L, Zacchigna S, et al. (2006) Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 98: 954-961.
7. Crottogini A, Meckert PC, Vera Janavel G, Lascano E, Negroni J, et al. (2003) Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther 14: 1307-1318.
8. Rafii S, Meeus S, Dias S, Hattori K, Heissig B, et al. (2002) Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 13: 61-67.
9. Zhou L, Ma W, Yang Z, Zhang F, Lu L, et al. (2005) VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 12: 196-202.
10. Jacquier A, Higgins CB, Martin AJ, Do L, Saloner D, et al. (2007) Injection of adeno-associated viral vector encoding vascular endothelial growth factor gene in infarcted swine myocardium: MR measurements of left ventricular function and strain. Radiology 245: 196-205.
11. Saeed M, Saloner D, Martin A, Do L, Weber O, et al. (2007) Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine. Radiology 243: 451-460.
12. Suckau L, Fechner H, Chemaly E, Krohn S, Hadri L, et al. (2009) Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation 119: 1241-1252.
13. Cheng Z, Ou L, Zhou X, Li F, Jia X, et al. (2008) Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16: 571-579.
14. Hofmann A, Wenzel D, Becher UM, Freitag DF, Klein AM, et al. (2009) Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A 106: 44-49.
15. Li W, Ma N, Ong LL, Kaminski A, Skrabal C, et al. (2008) Enhanced thoracic gene delivery by magnetic nanobead-mediated vector. J Gene Med 10: 897-909.
16. Li W, Nesselmann C, Zhou ZH, Ong LL, Ori F, et al. (2007) Gene delivery to the heart by magnetic nanobeads. Journal of Magnetism and Magnetic Materials 311: 336-341.
17. Delyagina E, Li W, Ma N, Steinhoff G, (2011) Magnetic targeting strategies in gene delivery. Nanomedicine (Lond) 6: 1593-1604.
18. Forbes ZG, Yellen BB, Barbee KA, Friedman G, (2003) An approach to targeted drug delivery based on uniform magnetic fields. Ieee Transactions on Magnetics 39: 3372-3377.
19. Torchilin VP, (2000) Drug targeting. Eur J Pharm Sci 11: S81-91.
20. Gaebel R, Ma N, Liu J, Guan J, Koch L, et al. (2011) Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration. Biomaterials 32: 9218-9230.
21. Wang W, Li W, Ong LL, Furlani D, Kaminski A, et al. (2010) Localized SDF-1alpha gene release mediated by collagen substrate induces CD117 stem cells homing. J Cell Mol Med 14: 392-402.
22. Wang W, Li W, Ong LL, Lutzow K, Lendlein A, et al. (2009) Localized and sustained SDF-1 gene release mediated by fibronectin films: A potential method for recruiting stem cells. Int J Artif Organs 32: 141-149.
23. Wang W, Li W, Ou L, Flick E, Mark P, et al. (2011) Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J Cell Mol Med 15: 1989-1998.
24. Furlani D, Klopsch C, Gabel R, Ugurlucan M, Pittermann E, et al. (2008) Intracardiac erythropoietin injection reveals antiinflammatory potential and improved cardiac functions detected by Forced Swim Test. Transplant Proc 40: 962-966.
25. Ou LL, Li WZ, Zhang Y, Wang WW, Liu J, et al. (2011) Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med 15: 1310-1318.
26. Ou L, Li W, Liu Y, Zhang Y, Jie S, et al. (2010) Animal models of cardiac disease and stem cell therapy. Open Cardiovasc Med J 4: 231-239.
27. Curato C, Slavic S, Dong J, Skorska A, Altarche-Xifro W, et al. (2010) Identification of Noncytotoxic and IL-10-Producing CD8(+) AT2R(+) T Cell Population in Response to Ischemic Heart Injury. Journal of Immunology 185: 6286-6293.
28. Emmrich S, Wang W, John K, Li W, Putzer BM, (2009) Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. Mol Cancer 8: 61.
29. Green NM, (1990) Avidin and streptavidin. Methods Enzymol 184: 51-67.
30. Wilchek M, Bayer EA, (1999) Foreword and introduction to the book (strept)avidin-biotin system. Biomol Eng 16: 1-4.
31. Pandori M, Hobson D, Sano T, (2002) Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology 299: 204-212.
32. Mykhaylyk O, Steingotter A, Perea H, Aigner J, Botnar R, et al. (2009) Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI. J Biomed Nanotechnol 5: 692-706.
33. Haynesworth SE, Baber MA, Caplan AI, (1996) Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166: 585-592.
34. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, et al. (2001) A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 98: 5780-5785.
35. Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, et al. (2004) A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 43: 734-741.
36. Abedi H, Zachary I, (1997) Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272: 15442-15451.
37. Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, et al. (2003) Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 310: 1002-1009.
38. Guerrero M, Athota K, Moy J, Mehta LS, Laguens R, et al. (2008) Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction. J Interv Cardiol 21: 242-251.
39. Yang TC, Millar J, Groves T, Zhou W, Grinshtein N, et al. (2007) On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines. Mol Ther 15: 997-1006.
40. Katare R, Caporali A, Zentilin L, Avolio E, Sala-Newby G,et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res 108: 1238-1251.
41. Meloni M, Descamps B, Caporali A, Zentilin L, Floris I, et al. (2012) Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes 61: 229-240.